Managing Director
Pharmalytik
Newark, Delaware
Kim Huynh-Ba is the Executive Director of Pharmalytik. She over 30 years of experience in quality systems, CMC, strategic drug development, and stability sciences. She is an Adjunct Professor at Temple University and Illinois Institute of Technology teaching Pharmaceutical Analysis, Quality Audit, Good Manufacturing Practices, and ICH Quality Guidelines.
Kim is a member of the USP Council of Experts (2015-2025), Chair of the Small Molecules 4 Expert Committee, a member of the USP Organic Impurities of Drug Products Expert Panel, and the USP Supplier Qualification Expert Panel. Kim is a member of the EAS Governing Board and their 2013 President. She is a member of the PQRI Stability Shelf Life Working Group and PDA's Supply Chain Qualification Group.
Kim takes part in the Editorial Board of the AAPS Open Access, of the Journal of GXP Compliance, and The Journal of Validation Technology. Kim has authored over 40 publications and book chapters. She has presented over 200 presentations, both domestic and internationally. She is the editor of the "Handbook of Stability Testing in Pharmaceutical Development"(2008), “Pharmaceutical Stability Testing to Support Global Markets"(2010), and "Analytical Chemistry: An Introduction to the GMP Pharmaceutical Lab"(4/2022). Kim was named Fellow at 2020 AAPS PharmSci 360.
Disclosure information not submitted.
Tuesday, October 18, 2022
9:00 AM – 10:00 AM ET
Tuesday, October 18, 2022
12:00 PM – 1:00 PM ET
Tuesday, October 18, 2022
2:30 PM – 3:30 PM ET
Tuesday, October 18, 2022
5:00 PM – 6:00 PM ET